title: [Serum concentrations of glucose, cholesterol and triglycerides in men with prolactinoma treated with cabergoline].
authors.affiliation: Servicio de Endocrinología, Hospital Universitario Ramón y Cajal, Departamento de Medicina, Universidad de Alcalá de Henares, Madrid, España. Electronic address: piglo65@gmail.com.
authors.forename: Pedro
authors.initials: P
authors.lastname: Iglesias
authors.affiliation: Servicio de Endocrinología, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España.
authors.forename: Carles
authors.initials: C
authors.lastname: Villabona
authors.affiliation: Servicio de Endocrinología, Hospital Universitario Ramón y Cajal, Departamento de Medicina, Universidad de Alcalá de Henares, Madrid, España.
authors.forename: Juan José
authors.initials: JJ
authors.lastname: Díez
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism*; D000077465:Cabergoline; D002784:Cholesterol / Q000097:blood*; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000097:blood / Q000188:drug therapy*; D015175:Prolactinoma / Q000097:blood / Q000188:drug therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood*
chemical_list: D000970:Antineoplastic Agents; D015415:Biomarkers; D001786:Blood Glucose; D004873:Ergolines; D014280:Triglycerides; D002784:Cholesterol; D000077465:Cabergoline